Posts filed under: News

Melbourne (Australia), Brussels (Belgium) – 18th of October 2018. Telix Pharmaceuticals Limited has today announced that the Company has received its first European Competent Authority (CA) approval to commence a...
Continue Reading →
Melbourne (Australia) and Nijmegen (the Netherlands) – 17 October 2018. Telix Pharmaceuticals Limited announced that it has concluded a GMP manufacturing agreement with Radboud Translational Medicine B.V. The full media...
Continue Reading →
Melbourne (Australia) and Seibersdorf (Austria) – 16 October 2018. Telix Pharmaceuticals Limited announced that it has entered into a commercial manufacturing agreement with Seibersdorf Labor GmbH. The full media release...
Continue Reading →
Melbourne (Australia) and Liège (Belgium) – 15 October 2018. Telix Pharmaceuticals Limited announced that it has expanded its partnership with Advanced Nuclear Medicine Ingredients SA for the 68Ga-HBED-CC-PSMA-11 (68Ga-PSMA) cold...
Continue Reading →
Melbourne (Australia) – 15 October 2018. Telix Pharmaceuticals Limited announced an extension to its master service agreement (MSA) with Cyclotek (Aust) Pty Ltd to include 89Zr-Girentuximab (TLX250-CDx) for imaging patients...
Continue Reading →
Melbourne (Australia) 15 October 2018. Telix Pharmaceuticals Limited announced that it has completed an interim analysis of the ZIR-DOSE dosimetry bridging study, conducted as part of Phase III readiness for...
Continue Reading →
Melbourne and Sydney (Australia) – 10 October 2018. Telix Pharmaceuticals Limited today announced that it has entered into a strategic collaboration agreement with GenesisCare Pty Ltd the largest private provider...
Continue Reading →
Indianapolis IN and Columbus OH (USA) – 3 October 2018. Telix Pharmaceuticals (US) Inc. a subsidiary of Telix Pharmaceuticals Limited, today announced that it has entered into a distribution agreement...
Continue Reading →
Melbourne (Australia) – 11 September 2018. Telix Pharmaceuticals Limited today announced the completion of the acquisition of Atlab Pharma SAS. To facilitate shareholder queries, the Company will be conducting an...
Continue Reading →
Melbourne (Australia) and Nantes (France) – 11 September 2018. Telix Pharmaceuticals Limited today announced the completion of the acquisition of Atlab Pharma SAS. For Market Briefing click here....
Continue Reading →